Whole Healthcare Magazine

respiratory studies, stretching from protocol
writing to conducting end to end studies.
Nearly three fourth of their experience has
been in the two most prevalent airway
diseases - Asthma and COPD. In the past
three years, they have been part of 14+
respiratory studies involving nearly 2500
patients at 70+ sites along with conducting 4
respiratory device studies. CCR's Investigator
database comprises 250+ investigators across
India with expertise in the respiratory.
CCR's experienced team of Data
Management, Clinical Operations, Project
Management, and Medical Affairs
professionals are well-versed in managing
and monitoring the procedures associated
with objectives and end points in respiratory
protocols. Their deep respiratory expertise
and focused operational staff enables them to
fill and complete clinical trials in the best
possible time, they maintain a network of
research associates, investigators and trial
sites with specific experience in pulmonary
indications enabling them to provide rapid
feasibility and help to meet the respiratory
trial goals.
“With our therapeutic and clinical expertise,
we focus together on your needs, and
strategically customized services for each
project allowing you to make decisions
quickly and move your development
programs forward at an express pace,”
expresses Satish.
CCR's Experience in Vaccine
Studies
CCR's Investigator database comprises 200+
investigators across India with expertise in
the Vaccine studies. Also, their experienced
team is highly trained in managing and
monitoring the procedures associated with
objectives and end points in Vaccine
protocols.
Maintaining deadlines are often determined
by seasonality or the spread of disease.
Besides, it is difficult to compress timelines in
the stages of vaccine development and
production. Croissance Clinical Research has
optimized many of the time-critical
operational processes in clinical trials of
vaccines to make your vaccine reach market
at the earliest. CCR understands the unique
challenges associated with vaccine
development and takes your objectives to
heart.
CCR has been part of 15+ vaccine studies
involving nearly 10157 patients at 120+ sites.
Croissance Clinical Research Team
Croissance has a diverse, talented team of
clinical development professionals who have
been exceeding client expectations.
Croissance experts can help you in making
smarter decisions and more confident choices.
Their high percentage of repeat and referral
business is evidence that they have earned
client confidence and loyalty.
"Our leading milestone in a short span of
time has been to be a part of multiple
successful phase III trials and getting the
marketing, manufacturing approvals for the
drugs, vaccines, and medical devices. It is
Croissance's endeavor to become a reliable
service provider globally for small and
midsize pharmaceutical and biotech
companies. Croissance Clinical Research's
passion and drive for excellence are strong,
and we are optimistic about the future of our
company and the industry. We envision being
a CRO with operations in US and Europe by
2021," said Satish Marukurthi, CEO of
Croissance.
Offering Best and Dedicated
Services
"Our journey was not a bed of roses,
Croissance has passed through many
footraces and our first project started with
auditing a site. We have been providing many
standalone services as well, and our first end
to end project was worth of 80 lakhs.
Irrespective of the size of the projects offered
to us, our team has dedicatedly provided
quality service to all the clients," Croissance.
With the right people and broad-based
expertise, CCR has long standing therapeutic
experience and a depth of clinical trial
knowledge. In the near future, the company is
expecting to become a globally recognized
brand among CRO industry